K
Keith M. Sullivan
Researcher at Duke University
Publications - 458
Citations - 40788
Keith M. Sullivan is an academic researcher from Duke University. The author has contributed to research in topics: Transplantation & Total body irradiation. The author has an hindex of 105, co-authored 447 publications receiving 39067 citations. Previous affiliations of Keith M. Sullivan include American Cancer Society & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Course of Crohn's disease after allogeneic marrow transplantation
TL;DR: It is suggested that host immune dysregulation plays a role in the perpetuation of Crohn's disease that can be corrected by allogeneic hematopoietic cell transplantation.
Journal Article
The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation.
Reginald A. Clift,Buckner Cd,Thomas Ed,Kenneth J. Kopecky,F R Appelbaum,Martin S. Tallman,R Storb,Jean E. Sanders,Keith M. Sullivan,Banaji M +9 more
TL;DR: Acute graft-versus-host disease (GVHD) had a major adverse effect on survival, but chronic GVHD decreased the risk of relapse for patients transplanted in first remission.
Journal Article
Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants.
Paul J. Martin,John A. Hansen,Beverly Torok-Storb,D M Durnam,Donna Przepiorka,J O'Quigley,Jean E. Sanders,Keith M. Sullivan,Robert P. Witherspoon,H. J. Deeg +9 more
TL;DR: The effect of primary diagnosis and the inverse relationship between the amount of pretransplant TBI and the graft failure rate suggest that a host factor may have been involved in a presumably immune-mediated rejection and leads to the inference that certain T cells present in donor marrow can suppress host immunity or help to maintain function of the graft.
Journal ArticleDOI
Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation
TL;DR: Almost all long-term survivors were leading full and meaningful lives, and demonstrated good mood and low psychological distress compared to cancer and population norms, and had the same perceptions as the general population of their current health and expectation of future health.
Journal ArticleDOI
Pathophysiology and treatment of graft-versus-host disease
TL;DR: The pathophysiology, incidence and predictive factors, clinical manifestations, diagnosis and grading, prevention, and treatment for both types of the disease are discussed.